Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Daiichi Sankyo
Chinese Patent Office
Boehringer Ingelheim
AstraZeneca
US Army

Generated: August 26, 2019

DrugPatentWatch Database Preview

Profile for Eurasian Patent Organization Patent: 031719

  Try a free trial


See Plans and Pricing

« Back to Dashboard

US Patent Family Members and Approved Drugs for Eurasian Patent Organization Patent: 031719

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
➤ Sign Up Nov 21, 2034 Novartis Pharms Corp JADENU deferasirox
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Chinese Patent Office
Argus Health
AstraZeneca
Deloitte
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.